Zynquista

Lexicon Pharma shares plummet after FDA denies appeal against drug rejection
Reuters
Tue, 12/3/19 - 12:08 am
Lexicon Pharmaceuticals
FDA
type 1 diabetes
Zynquista
Sanofi paying Lexicon $260M to exit diabetes alliance
BioPharma Dive
Wed, 09/11/19 - 12:51 pm
Sanofi
Lexicon Pharmaceuticals
diabetes
type 1 diabetes
Zynquista
Sanofi ends partnership with Lexicon after trial failure
In-Pharma Technologist
Mon, 08/5/19 - 10:45 pm
Sanofi
Lexicon Pharmaceuticals
clinical trials
Zynquista
diabetes
What's Next for Lexicon Pharmaceuticals?
Motley Fool
Mon, 03/25/19 - 10:21 pm
Lexicon Pharmaceuticals
sotagliflozin
Zynquista
Sanofi
diabetes
Sanofi, Lexicon get complete response letter for Zynquista
BioCentury
Fri, 03/22/19 - 10:08 pm
Sanofi
Zynquista
Lexicon Pharmaceuticals
type 1 diabetes
FDA
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Sat, 03/16/19 - 12:25 pm
Roche
SAGE Therapeutics
Ligand Pharmaceuticals
brexanolone
Tecentriq
Jazz Pharmaceuticals
JZP-110
Sanofi
Lexicon Pharmaceuticals
Zynquista
PhaseBio
AstraZeneca
Amarin
Leap Therapeutics
Strongbridge
3 Top Diabetes Stocks to Watch in February
Motley Fool
Mon, 02/18/19 - 11:17 am
diabetes
Zynquista
Lexicon Pharmaceuticals
devices
Tandem Diabetes
insulin pumps
Insulet
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
Pharmaforum
Fri, 01/18/19 - 10:26 am
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
Zynquista
FDA
advisory panels
sotagliflozin